Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Paratek Pharmaceuticals (United States) | Researchclopedia

Back to institutions

Paratek Pharmaceuticals (United States)

Boston, Massachusettscompany

216

Works

20,153

Citations

81

h-index

Top Research Topics

Antibiotic Resistance in Bacteria Antibiotics Pharmacokinetics and Efficacy Antimicrobial Resistance in Staphylococcus

Top Researchers

Kevin Winthrop Portland State University

803 works48,878 citationsh-index: 102

Recent Research

Omadacycline Monotherapy in Nontuberculous Mycobacterial Pulmonary Disease Caused by <i>Mycobacterium abscessus</i> : Results From a Phase 2, Double-blind, Randomized, Placebo-controlled Study

Kevin L Winthrop,Patrick A. Flume,et al.

20260 citations

Antibiotic Use and Resistance

Pneumonia and Respiratory Infections

Clostridium difficile and Clostridium perfringens research

Tuberculosis Research and Epidemiology

Mycobacterium research and diagnosis

Bacterial Identification and Susceptibility Testing

Microwave Engineering and Waveguides

Streptococcal Infections and Treatments

Acoustic Wave Resonator Technologies

Yimei Zhu Central South University

1,153 works40,279 citationsh-index: 93

Stuart B. Levy Federation University

372 works35,089 citationsh-index: 84

C. Robert Horsburgh Boston University

523 works30,102 citationsh-index: 79

Paul B. Eckburg Spero Therapeutics (United States)

66 works17,901 citationsh-index: 27

Evan Loh Singapore General Hospital

134 works15,047 citationsh-index: 41

Available datapackage for dataset 'KEYSTONE'

20260 citations

P-1535. Omadacycline was Shown to Preserve the Microbiome in a Murine Model of Post-Influenza MRSA Pneumonia

Sumiko Gomi,Emily Price,et al.

20260 citations

P-618. Pooled Microbiological Outcomes from the Phase 3, Randomized OPTIC and OPTIC-2 Trials of Omadacycline vs Moxifloxacin in Community-acquired Bacterial Pneumonia

Diane Anastasiou,Surya Chitra,et al.

20260 citations

P-1182. In Vitro Activity of Omadacycline and Comparator Agents Against Periodontal Pathogens

Courtenay J Kelley,Angela K Mendez,et al.

20260 citations

336. Microbiological Outcomes of Oral Omadacycline Treatment in Adults with Nontuberculous Mycobacterial Pulmonary Disease (NTM-PD) Caused by Mycobacterium abscessus complex (MABc): Results from a Phase 2, Double-blind, Randomized, Placebo-controlled, Multi-center Trial

Reeti Khare,Diane Anastasiou,et al.

20260 citations